Boston Scientific Corp. BSX

What this company does

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices used in a broad range of interventional medical specialties. As of December 31, 2025, it had approximately 59,000 employees, of which approximately 60 percent were outside the U.S. It markets its products and solutions to hospitals, clinics, outpatient facilities and medical offices in 127 countries worldwide. The company organizes its core businesses into two reportable segments: MedSurg and Cardiovascular. Its Endoscopy business unit, within MedSurg, develops and manufactures minimally invasive devices for diagnosing and treating gastrointestinal and pancreaticobiliary conditions and for supporting weight loss in patients with obesity. The Urology business unit develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction and male incontinence, overactive bladder and pelvic floor disorders. Within Cardiovascular, the Interventional Cardiology and Vascular Therapies business unit develops and manufactures technologies to diagnose and treat complex coronary, peripheral and venous diseases, including calcific and obstructive arterial disease, thromboembolic conditions and venous insufficiency.

Written from the business description in BOSTON SCIENTIFIC CORP's annual report to the U.S. Securities and Exchange Commission, filed 17 February 2026. Every sentence was checked against that document before publication.